Photograph of Jeff Nichols

Jeff Nichols


Jeff Nichols is a trusted advisor, problem solver, and accomplished litigator. He achieves outstanding results for clients in important, high-stakes litigation.

Jeff is also a leader. He presently serves as the co-lead of Crowell & Moring's PTAB and Post-Grant Proceedings practice. Prior to joining Crowell & Moring, he served as the Chair of the Litigation Group as well as Chair of the BioPharma Practice Group at his prior firm.

Jeff has extensive patent litigation experience. He is tenacious about achieving successful results for clients in a timely, efficient manner, while ensuring that these results align with business objectives. Clients seek out Jeff for important litigations due to his strong experience and track record of success. Jeff also focuses on patent post-grant proceedings, such as Inter Partes Review (IPR) proceedings. There, too, Jeff has achieved successful results for clients.

Jeff regularly appears in “Leading Lawyer” and “Super Lawyers” publications, and he has written numerous scholarly articles and client alerts throughout his career. He also regularly takes on speaking engagements concerning patent litigation and post-grant proceedings. And Jeff also worked to educate future intellectual property litigators. He was an adjunct professor at The John Marshall Law School in Chicago where he taught Intellectual Property Litigation from 2010 to 2018.


  • Truman State University, B.S. chemistry (1997)
  • University of Connecticut School of Law, J.D. (2000) with honors


  • Intellectual Property Owners Association
  • Intellectual Property Law Association of Chicago
  • PTAB Bar Association
  • Lawyers for the Creative Arts


Admitted to practice: U.S. Patent and Trademark Office (USPTO); U.S. Supreme Court; U.S. Court of Appeals, Federal, Ninth, and Seventh Circuits; U.S. District Court for Northern District of Illinois, Trial Bar; U.S. District Court for the Eastern District of Wisconsin; U.S. District Court for the Eastern District of Michigan; U.S. District Court for the Southern District of Indiana; U.S. District Court for the Northern District of Florida; Illinois Supreme Court

View More

"Is the PTAB Trending Patent Friendly?," IP Insights (March 2, 2021). Contact: Jeff Nichols
Client Alert / Newsletter
"Trending Down: PTAB Institution Rates Continue to Decline," IP Insights (March 20, 2020). Contact: Jeff Nichols
Client Alert / Newsletter
"Janssen Biotech Unable To Rewrite History and Save Remicade Patent," IP Insights (January 25, 2018). Contact: Jeff Nichols
Client Alert / Newsletter
Chicago Daily Law Bulletin Mentions Brinks Attorneys Chicago Daily Law Bulletin (March 27, 2017)
Press Coverage
Brinks Attorneys Mentioned in the Chicago Daily Law Bulletin Chicago Daily Law Bulletin (March 10, 2017)
Press Coverage
Jeff Nichols mentioned in CDLB Chicago Daily Law Bulletin (June 23, 2015)
Press Coverage
Jeffry Nichols quoted in Law360 Law360 (January 20, 2015)
Press Coverage
USPTO Issues Revised Guidelines For Patent Eligibility (January 8, 2015). Author: Jeff Nichols
Federal Circuit Denies En Banc Rehearing for Hepatitis Drug Patent Ruling (October 27, 2014). Authors: Joshua James and Jeff Nichols
"Patent Validity Challenges in the Medical Device and Diagnostic Industry," IP Frontline (November 16, 2011). Author: Jeff Nichols

For all Highlights, News & Knowledge, please click here to view desktop bio.

Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia that represents clients in litigation and arbitration, regulatory and policy, and transactional and corporate matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation and government-facing matters, as well as its ongoing commitment to pro bono service and diversity, equity, and inclusion.

View Desktop Site | Mobile Sitemap |

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2022
Attorney advertising - prior results do not guarantee a similar outcome.